Medtronic (MDT) Return on Capital Employed (2015 - 2026)

Medtronic (MDT) has 12 years of Return on Capital Employed data on file, last reported at 8.02% in Q2 2026.

• For the quarter ending Q2 2026, Return on Capital Employed rose 39.0% year-over-year to 8.02%; the trailing twelve-month figure through Apr 2026 stood at 8.02% (up 39.0% YoY), and the FY2026 full-year result was 8.01%, up 37.0% from the prior year.
• Return on Capital Employed advanced to 8.02% in Q2 2026, from 7.36% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 8.02% in Q2 2026 to a low of 6.46% in Q2 2024.
• A 5-year average of 7.19% and a median of 7.09% in 2023 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed soared 306 bps in 2022 and sank 100 bps in 2023, its largest moves.
• Tracing MDT's Return on Capital Employed over 5 years: stood at 7.6% in 2022, then fell by 9 bps to 6.89% in 2023, then climbed by 1 bps to 6.96% in 2024, then climbed by 10 bps to 7.65% in 2025, then increased by 5 bps to 8.02% in 2026.
• Business Quant data shows MDT's Return on Capital Employed at 8.02% in Q2 2026, 7.36% in Q1 2026, and 7.65% in Q4 2025.